RecruitingISRCTN83479057
This study is recruiting in Australia, in the United Kingdom, in Austria, .... It focuses on schizophrenia.
In AustraliaSchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Australia, United Kingdom, Austria, ...
- Sponsor
- University Medical Center Utrecht
- Condition
- Schizophrenia
RecruitingISRCTN77824516
This study is recruiting in Australia. It focuses on Depression.
In AustraliaDepressionOtherFrom 18 Years to 52 Years
- Countries
- Australia
- Sponsor
- Australian Centre for Mental Health Research
- Condition
- Depression
RecruitingISRCTN93903959
This study is recruiting in Australia. It is testing Internet-based interventions for depression.
Remote / onlineDepression, AnxietyOtherOver 18 Years
- Countries
- Australia
- Sponsor
- The Australian National University (Australia)
- Condition
- Depression, Anxiety
RecruitingNCT06793397
This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing a Deuterated Psilocin Analog for depression.
In AustraliaDepressionBehavioralFrom 18 Years to 85 Years
- Countries
- United States, Australia, United Kingdom, ...
- Sponsor
- Cybin IRL Limited
- Condition
- Depression
RecruitingISRCTN85247318
This study is recruiting in Australia. It is testing brain stimulation for ADHD.
In AustraliaADHDOtherFrom 18 Years to 35 Years
- Countries
- Australia
- Sponsor
- Neurode Labs Pty. Ltd.
- Condition
- ADHD
RecruitingNCT07412756
This study is recruiting in the United States, in Australia, in Canada, .... It is testing brenipatide for depression.
In AustraliaDepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
- Countries
- United States, Australia, Canada, ...
- Sponsor
- Eli Lilly and Company
- Condition
- Depression
RecruitingNCT06524830
This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for depression.
In AustraliaDepressionDrugFrom 18 Years to 65 Years
- Countries
- United States, Australia, Canada, ...
- Sponsor
- atai Therapeutics, Inc.
- Condition
- Depression
RecruitingNCT06929273
This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.
In AustraliaBipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States, Australia, France, ...
- Sponsor
- Bristol-Myers Squibb
- Condition
- Bipolarity
RecruitingNCT06947941
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Safety and Efficacy of KarXT + KarX-EC for Schizophrenia.
In AustraliaSchizophreniaDrugFrom 55 Years to 90 Years
- Countries
- United States, Australia, Canada, ...
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
RecruitingNCT06951698
This study is recruiting in the United States, in Australia, in New Zealand, .... It is testing KarXT for manic episodes in bipolarity type I.
In AustraliaBipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States, Australia, New Zealand, ...
- Sponsor
- Bristol-Myers Squibb
- Condition
- Bipolarity
RecruitingNCT07196501
This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.
In AustraliaDepressionDrugOver 18 Years
- Countries
- United States, Australia, Canada, ...
- Sponsor
- Neurocrine Biosciences
- Condition
- Depression
RecruitingISRCTN85462326
This study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom and Australia.
In AustraliaAnxietyOtherFrom 60 Years to 100 Years
- Countries
- Australia, United Kingdom
- Sponsor
- Camden and Islington NHS Foundation Trust
- Condition
- Anxiety
